All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @simplysmallscreations on TikTok · 61s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @simplysmallscreations's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Okay guys, I already set my pen up. I'm ready to take my shot. You can see the little drip at the end.
  2. 0:06So I'm not going to show my house down like that.
  3. 0:08But one thing I am going to say is that if you have stretch marks,
  4. 0:12make sure that you don't put the needle right there in the stretch mark.
  5. 0:15Because to me that seems to hurt a lot more. So go on the side of that where on the skin that
  6. 0:19doesn't have a stretch mark. To me it doesn't hurt. If I do it inside the stretch mark,
  7. 0:25I can feel it a lot more. So this is a tip for me that I use.
  8. 0:49The cap is back on. You don't have to put this in that one. I just do.
  9. 0:54Take this off and then I'm going to put this in the shot's box.

Saxenda journey videos: what the liraglutide science actually shows

Simplysmallscreations

TikTok creator

39.6K viewsWatch on TikTok

Quick answer

The creator is using liraglutide (Saxenda), a once-daily GLP-1 receptor agonist administered subcutaneously, and shares a personal pain-reduction strategy of avoiding injection directly into stretch marks. While striae distensae do involve altered dermal architecture that could plausibly affect needle sensation, no peer-reviewed data directly confirms that stretch marks increase injection pain for GLP-1 medications. The more clinically significant injection-site concern for subcutaneous GLP-1 medications is lipohypertrophy, which affects drug absorption and is not mentioned in this video.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Saxenda journey videos: what the liraglutide science actually shows, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

Compounded Semaglutide is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Saxenda journey videos: what the liraglutide science actually shows" from Simplysmallscreations. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is using liraglutide (Saxenda), a once-daily GLP-1 receptor agonist administered subcutaneously, and shares a personal pain-reduction strategy of avoiding injection directly into stretch marks.

The reason this review is not generic is the source wording and the canonical claim label "glp1 saxenda weightloss wegovy zepbound injection dailyinjection." In this clip, the useful excerpt is: "Okay guys, I already set my pen up." That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Striae distensae involve disrupted collagen, elastin, and altered nerve architecture, which gives the creator's tip some biological plausibility, but plausible is not the same as proven.
People who land here are usually comparing the Compounded Semaglutide claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Compounded Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator is using liraglutide (Saxenda), a once-daily GLP-1 receptor agonist administered subcutaneously, and shares a personal pain-reduction strategy of avoiding injection directly into stretch marks.

FormBlends verdict

Compounded Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator is using liraglutide (Saxenda), a once-daily GLP-1 receptor agonist administered subcutaneously, and shares a personal pain-reduction strategy of avoiding injection directly into stretch marks. While striae distensae do involve altered dermal architecture that could plausibly affect needle sensation, no peer-reviewed data directly confirms that stretch marks increase injection pain for GLP-1 medications. The more clinically significant injection-site concern for subcutaneous GLP-1 medications is lipohypertrophy, which affects drug absorption and is not mentioned in this video.
  • No peer-reviewed study has directly tested whether stretch marks increase subcutaneous injection pain for GLP-1 medications like liraglutide.
  • Striae distensae involve disrupted collagen, elastin, and altered nerve architecture, which gives the creator's tip some biological plausibility, but plausible is not the same as proven.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • No peer-reviewed study has directly tested whether stretch marks increase subcutaneous injection pain for GLP-1 medications like liraglutide.
  • Striae distensae involve disrupted collagen, elastin, and altered nerve architecture, which gives the creator's tip some biological plausibility, but plausible is not the same as proven.
  • Frid et al. (2020, Diabetes Technology and Therapeutics) found that lipohypertrophy at injection sites caused erratic subcutaneous medication absorption, which is a more clinically important site-selection issue than pain alone.
  • Usach et al. (2019, Journal of Pain Research) confirmed that local tissue composition significantly affects patient-reported injection pain, supporting the general idea that skin condition at the injection site matters.
  • The FDA prescribing information for Saxenda specifies site rotation among the abdomen, thigh, and upper arm, but does not address stretch marks specifically.
  • Disposing of used injection pens in a sharps container, as shown in this video, is correct practice and often skipped in similar content.
  • Pain during subcutaneous injection can result from injection speed, needle angle, skin temperature, and anxiety, not skin texture alone, per Taddio et al. (2021, Pain Reports).

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @simplysmallscreations actually say?

The creator shared a personal injection tip: avoid injecting directly into stretch marks because, in their experience, it hurts more. They said, "if you have stretch marks, make sure that you don't put the needle right there in the stretch mark" and noted that injecting beside the stretch mark feels painless to them personally. They also showed their post-injection routine of recapping the pen and disposing of it in a sharps container, which is worth paying attention to on its own.

To be clear, this is anecdotal self-reported pain tolerance advice, not a medical protocol. The creator is not claiming clinical authority here, and they frame it explicitly as "a tip for me that I use." That framing matters when we evaluate what follows.

Does the science back this up?

There is real biological reasoning here, even if the creator did not articulate it in clinical terms. Stretch marks, known clinically as striae distensae, involve structural changes to the dermis including disrupted collagen and elastin fibers and altered nerve density, which could plausibly affect injection sensation.

Research on subcutaneous injection pain has largely focused on needle gauge, injection speed, and injection site temperature rather than skin texture or striae specifically. A 2019 review by Usach et al. in the Journal of Pain Research examined factors affecting subcutaneous injection pain and found that tissue composition at the injection site, including variations in skin thickness and subcutaneous fat depth, significantly influenced patient-reported pain scores. Stretch-marked skin has measurably different dermal architecture. Whether that translates to more pain during needle insertion is not directly proven in a randomized trial, but the mechanism is biologically plausible. The FDA-approved prescribing information for liraglutide (Saxenda) recommends rotating injection sites among the abdomen, thigh, and upper arm, but does not address stretch marks at all.

What did they get wrong (or right)?

They got the sharps disposal part right. Showing the pen going into a sharps container is responsible content and something a lot of injection tutorial videos skip entirely. Credit where it is due.

The stretch mark tip itself is neither wrong nor right in any evidence-based sense. It is an unverifiable personal observation. The problem is not that they are lying. The problem is that individual pain perception varies enormously, and what hurts one person may not hurt another. A 2021 study by Taddio et al. in Pain Reports confirmed that subcutaneous injection pain is highly subjective and influenced by anxiety, prior experience, and skin sensitivity, none of which are controlled for in a single person's anecdotal report.

What they did not address, and probably should have, is that injecting into fibrotic or scar tissue, which can be present with older stretch marks, may affect drug absorption. That is a more clinically relevant concern than pain alone, and it is absent from this video entirely.

What should you actually know?

If you are using Saxenda or any subcutaneous GLP-1 medication, the practical injection guidance that actually has clinical backing includes rotating sites to prevent lipohypertrophy, which is a buildup of fatty tissue that can impair drug absorption. A 2020 paper by Frid et al. in Diabetes Technology and Therapeutics found that injecting into lipohypertrophic tissue was associated with erratic insulin and subcutaneous medication absorption in a significant portion of patients studied.

The stretch mark avoidance tip may reduce discomfort for some people, and there is no reason to dismiss it outright. But it should not replace standard injection guidance from your prescribing clinician. Site rotation, injection depth appropriate for your body composition, and consistent sharps disposal are the evidence-supported practices that belong at the center of any injection routine.

  • Always rotate injection sites across the recommended anatomical areas.
  • Avoid injecting into areas with visible lipohypertrophy, which feels rubbery or lumpy under the skin.
  • If stretch marks are extensive across your usual injection site, ask your prescriber or pharmacist about alternative locations.
  • Pain during injection can signal poor technique, not just skin texture issues.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Simplysmallscreations · TikTok creator

39.6K views on this video

#saxenda #weightloss #wegovy #zepbound #injection #dailyinjection #journey #saxendajourney #progress #dailyshot #thisishowwedoit #daily #shots #update #results #liraglutide #glp #glp1 #

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about no peer-reviewed study has directly tested whether stretch marks increase?

No peer-reviewed study has directly tested whether stretch marks increase subcutaneous injection pain for GLP-1 medications like liraglutide.

What does the video say about striae distensae involve disrupted collagen, elastin,?

Striae distensae involve disrupted collagen, elastin, and altered nerve architecture, which gives the creator's tip some biological plausibility, but plausible is not the same as proven.

What does the video say about frid et al. (2020, diabetes technology?

Frid et al. (2020, Diabetes Technology and Therapeutics) found that lipohypertrophy at injection sites caused erratic subcutaneous medication absorption, which is a more clinically important site-selection issue than pain alone.

What does the video say about usach et al. (2019, journal of pain research) confirmed?

Usach et al. (2019, Journal of Pain Research) confirmed that local tissue composition significantly affects patient-reported injection pain, supporting the general idea that skin condition at the injection site matters.

What does the video say about the fda prescribing information for saxenda specifies site rotation among?

The FDA prescribing information for Saxenda specifies site rotation among the abdomen, thigh, and upper arm, but does not address stretch marks specifically.

What does the video say about disposing of used injection pens in a sharps container, as?

Disposing of used injection pens in a sharps container, as shown in this video, is correct practice and often skipped in similar content.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Simplysmallscreations, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.